CD4 and hepatocellular carcinoma: As expected, our results revealed that HCC patients with high expression of RENT3B exhibited a poorer prognosis in the enriched and decreased cohorts of B cells, CD4+ T cells, CD8+ T cells, Macrophages, Th1 cells, and Th2 cells (Fig. 6).